106PSafety and efficacy of trifluridine/tipiracil (TAS-102) plus bevacizumab in clinical practice for patients with refractory metastatic colorectal cancer. (25th November 2018) - Kotani, D; Kuboki, Y; Yasuda, K; Nakamura, Y; Kawazoe, A; Bando, H; Taniguchi, H; Shitara, K; Yoshino, T